MedTrace Logo

Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

NCT00483249 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2026-03-05

No results posted yet for this study

Summary

This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.

Conditions

  • Thoracoabdominal Aortic Aneurysm
  • Paravisceral Abdominal Aortic Aneurysm

Interventions

DEVICE

Endovascular Branched Stent-Graft

Industry manufactured branched stent-graft for treatment of TAAA/PVAAA.

Sponsors & Collaborators

  • Warren J. Gasper, MD

    lead OTHER

Principal Investigators

  • Warren J Gasper, MD · University of California, San Francisco

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2027-12-31
Completion
2027-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00483249 on ClinicalTrials.gov